Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Edarbyclor in Grade 2-3 Essential Hypertension
NCT01456169Phase 3Completed
- Sponsor
- Takeda
- Start
- Oct 2011
- Primary completion
- Dec 2012
- Countries
- 14
01
Overview
A Phase 3 trial of azilsartan medoxomil + chlorthalidone in essential hypertension, sponsored by Takeda. Started Oct 2011; status: completed.
02
Drugs
azilsartan medoxomil + chlorthalidone
03
Conditions
essential hypertension
Beyond the preview
Go deeper on NCT01456169.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01456169.